Translumina launches Dual-Drug Polymer-free Coated Stent (DDCS)
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
Launch of novel stent technology with 10-year safety and efficacy data adds further momentum to the company's global growth journey
The studies demonstrate a standardized strategy to extend mechanistic modeling and systems pharmacology into drug safety and mode of action assessments that has relevance for drug development and a variety of other contexts
Cataract is the most common cause of blindness in India, and that diabetes is to be blamed for the massive number of damaged eyes
Flattish volume growth and subdued new launches were key factors for last month
Contribution from the top five therapies stood at 58% of IPM in October 2021. These therapies are cardiac, anti-infectives, gastro-intestinal, anti-diabetic and vitamins
India registers 18% of deaths annually due to air pollution while seven million die annually across the world due to air pollution
The segment delivered strong sales growth of 20% YoY
Subscribe To Our Newsletter & Stay Updated